The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status

High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism

(2018) Sophie Vacher et al.   PLoS One

Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival

(2018) Sophie Sixou et al.   Translational Oncology

Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)

(2017) M.J. Duffy et al.   EUROPEAN JOURNAL OF CANCER

A Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase

(2017) Sandra Luecke-Johansson et al.   MOLECULAR AND CELLULAR BIOLOGY

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

(2017) et al.   JAMA Oncology

Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta, accelerates vimentin degradation, and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells

(2016) Ching-Hao Li et al.   ARCHIVES OF TOXICOLOGY

Antioxidant Functions of the Aryl Hydrocarbon Receptor

(2016) Cornelia Dietrich   Stem Cells International

The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment

(2015) Markus Mandl et al.   Radiation Oncology

Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events

(2014) Carolin Bock et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells

(2014) E F O'Donnell et al.   Cell Death & Disease

Multicentric and multifocal versusunifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology

(2013) Tobias Weissenbacher et al.   BMC CANCER

Aryl Hydrocarbon Receptor in Breast Cancer—A Newly Defined Prognostic Marker

(2013) Ryoko Saito et al.   Hormones & Cancer

Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma

(2012) NINA DITSCH et al.   Oncology Letters

Aryl Hydrocarbon Receptor Modulation of Estrogen Receptor α-Mediated Gene Regulation by a Multimeric Chromatin Complex Involving the Two Receptors and the Coregulator RIP140

(2011) Zeynep Madak-Erdogan et al.   TOXICOLOGICAL SCIENCES

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

(2009) Balazs Györffy et al.   BREAST CANCER RESEARCH AND TREATMENT

Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4

(2009) M. A. Barhoover et al.   MOLECULAR PHARMACOLOGY